Indian pediatric experts report that Respiratory Syncytial Virus (RSV) causes a significant number of infant respiratory ...

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

SARS-CoV-2 infection in children and adolescents increases risk for cardiovascular disease, compared with uninfected individuals.

Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months.

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices.

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric respiratory syncytial virus (RSV) ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

Learn to recognize dangerous RSV symptoms in children beyond typical cold signs, including breathing changes, distinctive wheezing, and feeding difficulties.

RSV symptoms in adults vs. children: What's different and how long could it last? What should you know about RSV and who can get it?

RSV symptoms in adults and children are general and can look similar to most other respiratory viruses, making it difficult to self-diagnose, according to the CDC.